Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare
Eloxx Pharmaceuticals, Inc. Operating Income 2010–2025
Eloxx Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2010 to 2012. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Eloxx Pharmaceuticals, Inc. operating income for the quarter ending December 31, 2012 was -1.3 M, a 10.72% decrease year-over-year.
- Eloxx Pharmaceuticals, Inc. annual operating income for 2025 was -6.4 M, a 160.86% increase from 2024.
- Eloxx Pharmaceuticals, Inc. annual operating income for 2024 was -2.5 M, a 85.72% decrease from 2023.
- Eloxx Pharmaceuticals, Inc. annual operating income for 2023 was -17.3 M, a 88.99% increase from 2014.
- Eloxx Pharmaceuticals, Inc. annual operating income for 2014 was -9.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eloxx Pharmaceuticals, Inc. Operating Income — FAQ
Eloxx Pharmaceuticals, Inc. (ELOX) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Eloxx Pharmaceuticals, Inc.'s operating income?
Eloxx Pharmaceuticals, Inc. (ELOX) reported operating income of -$6M for fiscal 2025.
Where can I see ELOX's operating income history?
The chart and table above show Eloxx Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.